Federico Javier Wolman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Federico Javier Wolman has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- María Victoria Miranda
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina, Argentina
7 shared publications - María Fernanda Baieli
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
5 shared publications - Alexandra Marisa Targovnik
Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Universidad de Buenos Aires (UBA), Ciudad Autónoma de Buenos Aires C1113AAD, Argentina
3 shared publications - Osvaldo Cascone
University of Buenos Aires, Buenos Aires, Argentina
3 shared publications - Romina Julieta Glisoni
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Junín 956, C1113AAD Buenos Aires, Argentina
3 shared publications - Laura Daniela Pilato
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
2 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by MDPI AG in Journal of Pharmaceutical and BioTech Industry
- Vol. 3 (3) , 16
Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey
The development of strategies and processes to valorize cheese whey is an area of constant advancement and growth, primarily due to the large volume generated daily and inherent technical difficulties in cost-effectively processing this material. In this regard, the present perspective will discuss and analyze different strategies based on chromatographic innovations to develop processes that enable the direct and selective capture and purification of bovine lactoferrin (LF) and lactoperoxidase (LP) proteins from cheese whey. These proteins possess interesting commercial value and represent minor components of the whey protein fraction, with whey being their main source. Given that this issue is dedicated to the memory and career of Prof. Dr. Osvaldo Cascone, and considering his extensive research in this area, his contributions will be examined chronologically to illustrate the strategic technological advancements made by his research group. Specifically, the advancements achieved in terms of efficiency in the selectivity and purity obtained for the target proteins through the development of affinity chromatographic matrices and processes will be discussed, as well as the progress made in terms of whey processability.
- 8 July 2026
- Published by MDPI AG in Journal of Pharmaceutical and BioTech Industry
- Vol. 3 (3) , 16
Open AccessAdvances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey
The development of strategies and processes to valorize cheese whey is an area of constant advancement and growth, primarily due to the large volume generated daily and inherent technical difficulties in cost-effectively processing this material. In this regard, the present perspective will discuss and analyze different strategies based on chromatographic innovations to develop processes that enable the direct and selective capture and purification of bovine lactoferrin (LF) and lactoperoxidase (LP) proteins from cheese whey. These proteins possess interesting commercial value and represent minor components of the whey protein fraction, with whey being their main source. Given that this issue is dedicated to the memory and career of Prof. Dr. Osvaldo Cascone, and considering his extensive research in this area, his contributions will be examined chronologically to illustrate the strategic technological advancements made by his research group. Specifically, the advancements achieved in terms of efficiency in the selectivity and purity obtained for the target proteins through the development of affinity chromatographic matrices and processes will be discussed, as well as the progress made in terms of whey processability.
- Open Access
- 29 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22897-22915
Cooperative supramolecular integration of QS-21 into polymeric micelles as a tunable nanoadjuvant platform for subunit vaccines
Potent saponin adjuvants such as QS-21, used in clinically approved vaccine formulations, remain limited by intrinsic hemolytic activity and restricted aqueous stability, motivating biomaterials strategies aimed at regulating their interfacial behavior while preserving immunostimulatory function. Here, we show that when combined with amphiphilic PEO–PPO triblock copolymers (P123 and F127), QS-21 appears to participate in cooperative supramolecular integration into polymeric micelles rather than behaving as a passively encapsulated cargo. This architecture-dependent organization gives rise to structurally coherent nanosystems with enhanced dilution stability and controlled membrane activity. Comparative analysis revealed that P123/QS-21 assemblies form compact, monodisperse micelles (∼21 nm) with marked resistance to dilution, whereas F127-based systems display greater structural heterogeneity and reduced supramolecular robustness. Cooperative integration is associated with attenuation of hemolytic activity in a concentration-dependent manner relative to free QS-21 while preserving functional accessibility, consistent with controlled interfacial presentation of the saponin. These physicochemical features are supported by DLS, TEM, and NTA analyses. In vivo evaluation using a SARS-CoV-2 Spike subunit antigen indicates that P123/QS-21 is associated with enhanced systemic and mucosal antibody responses while inducing functional neutralizing activity. Together, these findings support cooperative supramolecular integration as a biomaterials design principle to modulate membrane activity and nanoadjuvant performance, providing a scalable and tunable framework for the development of subunit vaccine platforms.
- 29 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (25) , 22897-22915
Open AccessCooperative supramolecular integration of QS-21 into polymeric micelles as a tunable nanoadjuvant platform for subunit vaccines
Potent saponin adjuvants such as QS-21, used in clinically approved vaccine formulations, remain limited by intrinsic hemolytic activity and restricted aqueous stability, motivating biomaterials strategies aimed at regulating their interfacial behavior while preserving immunostimulatory function. Here, we show that when combined with amphiphilic PEO–PPO triblock copolymers (P123 and F127), QS-21 appears to participate in cooperative supramolecular integration into polymeric micelles rather than behaving as a passively encapsulated cargo. This architecture-dependent organization gives rise to structurally coherent nanosystems with enhanced dilution stability and controlled membrane activity. Comparative analysis revealed that P123/QS-21 assemblies form compact, monodisperse micelles (∼21 nm) with marked resistance to dilution, whereas F127-based systems display greater structural heterogeneity and reduced supramolecular robustness. Cooperative integration is associated with attenuation of hemolytic activity in a concentration-dependent manner relative to free QS-21 while preserving functional accessibility, consistent with controlled interfacial presentation of the saponin. These physicochemical features are supported by DLS, TEM, and NTA analyses. In vivo evaluation using a SARS-CoV-2 Spike subunit antigen indicates that P123/QS-21 is associated with enhanced systemic and mucosal antibody responses while inducing functional neutralizing activity. Together, these findings support cooperative supramolecular integration as a biomaterials design principle to modulate membrane activity and nanoadjuvant performance, providing a scalable and tunable framework for the development of subunit vaccine platforms.
- Open Access
- 20 March 2026
- Published by MDPI AG in Preprints.org
Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey
The development of strategies and processes to valorize cheese whey is an area of constant advancement and growth, primarily due to the large volume generated daily and inherent technical difficulties in cost-effectively processing this material. In this regard, the present review, with a critical perspective from the authors, will discuss and analyze different strategies based on chromatographic innovations to develop processes that enable the direct and selective capture and purification of bovine lactoferrin (LF) and lactoperoxidase (LP) proteins from cheese whey. These proteins possess interesting commercial value and represent minor components of the whey protein fraction, with whey being their main source. The advancements achieved in terms of efficiency in the selectivity and purity obtained for the target proteins through the development of affinity chromatographic matrices and processes will be discussed, as well as the progress made in terms of productivity and whey processability.
- 20 March 2026
- Published by MDPI AG in Preprints.org
Open AccessAdvances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey
The development of strategies and processes to valorize cheese whey is an area of constant advancement and growth, primarily due to the large volume generated daily and inherent technical difficulties in cost-effectively processing this material. In this regard, the present review, with a critical perspective from the authors, will discuss and analyze different strategies based on chromatographic innovations to develop processes that enable the direct and selective capture and purification of bovine lactoferrin (LF) and lactoperoxidase (LP) proteins from cheese whey. These proteins possess interesting commercial value and represent minor components of the whey protein fraction, with whey being their main source. The advancements achieved in terms of efficiency in the selectivity and purity obtained for the target proteins through the development of affinity chromatographic matrices and processes will be discussed, as well as the progress made in terms of productivity and whey processability.
- 13 March 2025
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 339
Induced porosity in chitin xerogels for use in protein adsorption and purification
- 13 March 2025
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 339
Induced porosity in chitin xerogels for use in protein adsorption and purification
- Open Access
- 8 November 2024
- Published by Elsevier in Nano Trends
- Vol. 8
Nanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations
- 8 November 2024
- Published by Elsevier in Nano Trends
- Vol. 8
Open AccessNanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations
- Open Access
Improved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System
Insect cell-baculovirus expression vector system is one of the most established platforms to produce biological products, and it plays a fundamental role in the context of COVID-19 emergency, providing recombinant proteins for treatment, diagnosis, and prevention. SARS-CoV-2 infection is mediated by the interaction of the spike glycoprotein trimer via its receptor-binding domain (RBD) with the host’s cellular receptor. As RBD is required for many applications, in the context of pandemic it is important to meet the challenge of producing a high amount of recombinant RBD (rRBD). For this reason, in the present study, we developed a process based on Sf9 insect cells to improve rRBD yield. rRBD was recovered from the supernatant of infected cells and easily purified by metal ion affinity chromatography, with a yield of 82% and purity higher than 95%. Expressed under a novel chimeric promoter (polh-pSeL), the yield of rRBD after purification was 21.1 ± 3.7 mg/L, which is the highest performance described in Sf9 cell lines. Finally, rRBD was successfully used in an assay to detect specific antibodies in COVID-19 serum samples. The efficient strategy herein described has the potential to produce high-quality rRBD in Sf9 cell line for diagnostic purpose.
Open AccessImproved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System
Insect cell-baculovirus expression vector system is one of the most established platforms to produce biological products, and it plays a fundamental role in the context of COVID-19 emergency, providing recombinant proteins for treatment, diagnosis, and prevention. SARS-CoV-2 infection is mediated by the interaction of the spike glycoprotein trimer via its receptor-binding domain (RBD) with the host’s cellular receptor. As RBD is required for many applications, in the context of pandemic it is important to meet the challenge of producing a high amount of recombinant RBD (rRBD). For this reason, in the present study, we developed a process based on Sf9 insect cells to improve rRBD yield. rRBD was recovered from the supernatant of infected cells and easily purified by metal ion affinity chromatography, with a yield of 82% and purity higher than 95%. Expressed under a novel chimeric promoter (polh-pSeL), the yield of rRBD after purification was 21.1 ± 3.7 mg/L, which is the highest performance described in Sf9 cell lines. Finally, rRBD was successfully used in an assay to detect specific antibodies in COVID-19 serum samples. The efficient strategy herein described has the potential to produce high-quality rRBD in Sf9 cell line for diagnostic purpose.
- Open Access
- 27 July 2018
- Published by Springer Nature in 3 Biotech
- Vol. 8 (8) , 341
Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus
Feline interferon beta is a cytokine that belongs to the type I IFN family, with antitumor, antiviral and immunomodulatory functions. In this work, recombinant feline interferon beta (rFeIFNβ) was expressed in insect larvae that constitute important agronomic plagues. rFeIFNβ accumulated in the hemolymph of Spodoptera frugiperda larvae infected with recombinant baculovirus and was purified by Blue-Sepharose chromatography directly from larval homogenates on day 4 post-infection. rFeIFNβ was recovered after purification with a specific activity of 1 × 106 IU mg−1. By this method, we obtained 8.9 × 104 IU of purified rFeIFNβ per larva. The product was biologically active in vitro, with an antiviral activity of 9.5 × 104 IU mL−1, as well as a potent antitumor activity comparable to that of the commercial FeIFNω. The glycosylation of rFeIFNβ was confirmed by peptide-N-glycosidase F digestion. Our findings provide a cost-effective platform for large-scale rFeIFNβ production in laboratory research or veterinary medicine applications.
- 27 July 2018
- Published by Springer Nature in 3 Biotech
- Vol. 8 (8) , 341
Open AccessProduction of biologically active feline interferon beta in insect larvae using a recombinant baculovirus
Feline interferon beta is a cytokine that belongs to the type I IFN family, with antitumor, antiviral and immunomodulatory functions. In this work, recombinant feline interferon beta (rFeIFNβ) was expressed in insect larvae that constitute important agronomic plagues. rFeIFNβ accumulated in the hemolymph of Spodoptera frugiperda larvae infected with recombinant baculovirus and was purified by Blue-Sepharose chromatography directly from larval homogenates on day 4 post-infection. rFeIFNβ was recovered after purification with a specific activity of 1 × 106 IU mg−1. By this method, we obtained 8.9 × 104 IU of purified rFeIFNβ per larva. The product was biologically active in vitro, with an antiviral activity of 9.5 × 104 IU mL−1, as well as a potent antitumor activity comparable to that of the commercial FeIFNω. The glycosylation of rFeIFNβ was confirmed by peptide-N-glycosidase F digestion. Our findings provide a cost-effective platform for large-scale rFeIFNβ production in laboratory research or veterinary medicine applications.
- Open Access
- 7 December 2017
- Published by Wiley in Biotechnology Progress
- Vol. 34 (2) , 387-396
Sulfanilic acid‐modified chitosan mini‐spheres and their application for lysozyme purification from egg white
A cation exchange matrix with zwitterionic and multimodal properties was synthesized by a simple reaction sequence coupling sulfanilic acid to a chitosan based support. The novel chromatographic matrix was physico‐chemically characterized by ss‐NMR and ζ potential, and its chromatographic performance was evaluated for lysozyme purification from diluted egg white. The maximum adsorption capacity, calculated according to Langmuir adsorption isotherm, was 50.07 ± 1.47 mg g −1 while the dissociation constant was 0.074 ± 0.012 mg mL −1 . The process for lysozyme purification from egg white was optimized, with 81.9% yield and a purity degree of 86.5%, according to RP‐HPLC analysis. This work shows novel possible applications of chitosan based materials. The simple synthesis reactions combined with the simple mode of use of the chitosan matrix represents a novel method to purify proteins from raw starting materials. © 2017 American Institute of Chemical Engineers Biotechnol. Prog. , 34:387–396, 2018
- 7 December 2017
- Published by Wiley in Biotechnology Progress
- Vol. 34 (2) , 387-396
Open AccessSulfanilic acid‐modified chitosan mini‐spheres and their application for lysozyme purification from egg white
A cation exchange matrix with zwitterionic and multimodal properties was synthesized by a simple reaction sequence coupling sulfanilic acid to a chitosan based support. The novel chromatographic matrix was physico‐chemically characterized by ss‐NMR and ζ potential, and its chromatographic performance was evaluated for lysozyme purification from diluted egg white. The maximum adsorption capacity, calculated according to Langmuir adsorption isotherm, was 50.07 ± 1.47 mg g −1 while the dissociation constant was 0.074 ± 0.012 mg mL −1 . The process for lysozyme purification from egg white was optimized, with 81.9% yield and a purity degree of 86.5%, according to RP‐HPLC analysis. This work shows novel possible applications of chitosan based materials. The simple synthesis reactions combined with the simple mode of use of the chitosan matrix represents a novel method to purify proteins from raw starting materials. © 2017 American Institute of Chemical Engineers Biotechnol. Prog. , 34:387–396, 2018
- 1 December 2013
- Published by Elsevier in Process Biochemistry
- Vol. 48 (12) , 1972-1979
Triazinic dye ligand selection by surface plasmon resonance for recombinant lactoferricin purification
- 1 December 2013
- Published by Elsevier in Process Biochemistry
- Vol. 48 (12) , 1972-1979
Triazinic dye ligand selection by surface plasmon resonance for recombinant lactoferricin purification
- 1 September 2009
- Published by Elsevier in New Biotechnology
- Vol. 25, S175-175
Development of a low-cost pseudobioaffinity chromatographic matrix for lactoferrin purification from milk or whey
- 1 September 2009
- Published by Elsevier in New Biotechnology
- Vol. 25, S175-175
Development of a low-cost pseudobioaffinity chromatographic matrix for lactoferrin purification from milk or whey